Andes Biotechnologies Global's Seed VC Round

Andes Biotechnologies Global raised a round of funding on December 15, 2017.

Andes Biotechnologies is a nucleic acid-based drug discovery and Development Company focused on solid tumor cancers. The company has discovered two novel families of long noncoding RNAs: sense (S-RNA)…

Articles about Andes Biotechnologies Global's Seed VC Round: